STOCK TITAN

Allogene: Griffin may be deemed to own 7.1% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Allogene Therapeutics, Inc. (ALLO) was the subject of a Schedule 13G reporting beneficial ownership as of September 30, 2026. Kenneth Griffin, President and Chief Executive Officer of Citadel GP LLC, may be deemed to beneficially own 24,680,425 shares, or 7.1%. Citadel Securities GP LLC and Citadel Securities Group LP each may be deemed to beneficially own 16,352,007 shares (4.7%); Citadel Securities LLC, 14,104,798 shares (4.1%); and Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC, 8,328,418 shares each (2.4%). The filing reports shared voting and dispositive power for these positions.

Beneficial ownership — Kenneth Griffin 24,680,425 shares May be deemed beneficially owned; 7.1% of the class
Beneficial ownership percentage — Kenneth Griffin 7.1% Based on 24,680,425 shares
Beneficial ownership — Citadel Securities GP LLC and Citadel Securities Group LP 16,352,007 shares each May be deemed beneficially owned; 4.7% of the class each
Beneficial ownership percentage — Citadel Securities GP LLC and Citadel Securities Group LP 4.7% each Based on 16,352,007 shares each
Beneficial ownership — Citadel Securities LLC 14,104,798 shares May be deemed beneficially owned; 4.1% of the class
Beneficial ownership percentage — Citadel Securities LLC 4.1% Based on 14,104,798 shares
Beneficial ownership — Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC 8,328,418 shares each May be deemed beneficially owned; 2.4% of the class each
Beneficial ownership percentage — Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC 2.4% each Based on 8,328,418 shares each
beneficially own regulatory
"may be deemed to beneficially own 24,680,425 Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared Voting Power regulatory
"Shared Voting Power 24,680,425.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 24,680,425.00"
exercisable for or convertible into Shares technical
"other instruments exercisable for or convertible into Shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALLO shares does Kenneth Griffin report as beneficially owned?

Kenneth Griffin, President and Chief Executive Officer of Citadel GP LLC, may be deemed to beneficially own 24,680,425 shares, or 7.1%.

How many shares outstanding were used to calculate ALLO ownership percentages?

The percentages are based on 345,490,881 shares outstanding as of August 10, 2026, according to Allogene Therapeutics' Form 10-Q filed on August 12, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





019770106

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages reported in this Schedule 13G are based upon 345,490,881 Shares outstanding as of August 10, 2026 (according to the issuer's Form 10-Q as filed with the Securities and Exchange Commission on August 12, 2026).


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Citadel Securities GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel Securities LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel Securities Group LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel Advisors LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel Advisors Holdings LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Citadel GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:11/16/2026
Kenneth Griffin
Signature:/s/ Seth Levy
Name/Title:Seth Levy, attorney-in-fact*
Date:11/16/2026

Comments accompanying signature: * Seth Levy is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Allakos Inc. on October 13, 2023.
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement

Keep reading